NCT06564688

Brief Summary

Swallowing activity in the oral phase is regulated by the cortical swallowing network, and the functional connectivity pattern of the cortical swallowing network is related to swallowing activity. The structural damage of the cortical swallowing network and abnormal activation of brain areas related to swallowing in post-stroke dysphagia affect swallowing activity. The recovery of dysphagia after stroke is related to the compensation of swallowing network in the contralateral hemisphere and different connectivity patterns of diseased brain areas, and the integrity of cortical swallowing network connectivity affects the sequence of oral swallowing activities. However, it is not clear how the functional connectivity patterns and interactions of brain regions of the cortical swallowing network related to oral swallowing activity change in patients with oral dysphagia after stroke.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
72

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2024

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 12, 2024

Completed
8 days until next milestone

Study Start

First participant enrolled

August 20, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 21, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
Last Updated

August 21, 2024

Status Verified

August 1, 2024

Enrollment Period

11 months

First QC Date

August 12, 2024

Last Update Submit

August 19, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Standard Swallowing Assessment (SSA)

    The scale has a minimum score of 18 and a maximum score of 46, with higher scores indicating poorer swallowing function

    Before fMRI scan

  • Oral Functional Scale

    The Oral Functional Scale is a tool used to assess the oral functional status of an individual, with higher scores indicating better oral function

    Baseline

Secondary Outcomes (1)

  • Functional Oral Intake Scale (FOIS)

    Baseline

Other Outcomes (2)

  • Videofluoroscopicdysphagia scale(VDS)

    Baseline

  • Water Swallowing Test (WST)

    Baseline

Study Arms (3)

Dysphagia in the oral phase after stroke

The swallowing function was assessed by swallowing related scale and the Videofluoroscopic Swallowing Study, and then functional magnetic resonance imaging was performed.

Diagnostic Test: Swallowing function test

Without dysphagia after stroke

First, the swallowing function related scale was evaluated, and then the functional magnetic resonance imaging (fMRI) scan was performed.

Diagnostic Test: Swallowing function test

Healthy controls

First, the swallowing function related scale was evaluated, and then the functional magnetic resonance imaging (fMRI) scan was performed.

Diagnostic Test: Swallowing function test

Interventions

The oral function score assesses the oral functional performance of chewing in all participants. The Functional oral feeding Scale (FOIS) was used to assess the ability of all participants to eat. The standardized swallowing assessment (SSA) was used to assess the global swallowing function of all participants.

Dysphagia in the oral phase after strokeHealthy controlsWithout dysphagia after stroke

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Three categories of population were included in this study: post-stroke dysphagia in the oral phase, post-stroke dysphagia without dysphagia, and healthy controls. The subjects with post-stroke dysphagia were mainly those with oral dysphagia caused by the first stroke, who were able to complete the assessment and scanning, and had no contraindications to MRI scanning. The course of post-stroke dysphagia was between 0 and 6 months. The subjects without dysphagia after stroke were free of swallowing dysfunction after first stroke, could complete the assessment and scan, the course of stroke was between 0 and 6 months, and there were no contraindications to MRI scanning. The healthy controls were healthy people with normal cognition, swallowing function, and no contraindications to MRI scanning.

You may qualify if:

  • Patients with dysphagia after first stroke, meeting the diagnostic criteria of stroke, and confirmed by brain CT or brain MRI;
  • Oral dysphagia caused by stroke;
  • FOIS level ≤ 5; WST level ≥3;
  • Those who can understand and carry out the simple instructions of the treatment staff and are willing to accept the examination and treatment;
  • Clear consciousness and stable vital signs;
  • Patients in the recovery stage with stroke course and dysphagia duration between 0 and 6 months;
  • Right-handed;
  • Voluntary participants with informed consent.
  • Patients with first-ever stroke, meeting the diagnostic criteria of stroke, and confirmed by brain CT or brain MRI;
  • No dysphagia, FOIS level =7; WST level =1;
  • Those who can understand and carry out the simple instructions of the treatment staff and are willing to accept the examination and treatment;
  • Clear consciousness and stable vital signs;
  • Patients in the recovery stage with stroke duration between 0 and 6 months;
  • Right-handed;
  • Voluntary participants with informed consent.
  • +4 more criteria

You may not qualify if:

  • Dysphagia not caused by stroke or non-oral dysphagia;
  • History of cerebral trauma, stroke, brain tumor, cerebrovascular, intracranial infection, Parkinson's disease, epilepsy, or other neurological or psychiatric diseases;
  • Symptoms of severe aphasia, neglect, visual field defect and other cortical lesions; Patients with severe cognitive impairment or depression;
  • Taking or within 2 weeks of taking drugs that affect the nervous system or psychoses;
  • Patients with metal implants and/or spatial claustrophobia who are not suitable for MRI scanning;
  • Visual/hearing disorders affecting training and assessment;
  • Persons who are participating in other research trials that may influence the results of this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Qingqing Zhang

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer

Study Record Dates

First Submitted

August 12, 2024

First Posted

August 21, 2024

Study Start

August 20, 2024

Primary Completion

July 1, 2025

Study Completion

July 1, 2025

Last Updated

August 21, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share